insights_auto
Why is VRTX down 4.30%?
Dive Deeperchevron_right
VRTX:NASDAQ
Vertex Pharmaceuticals Inc
$485.22
arrow_downward
-4.30%(-21.78) 1D
$486.20
arrow_upward
+0.20% (+0.98)bedtimeAfter hours
Closed: Oct 13, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for VRTX...
Open
$507.55
High
$508.57
Low
$484.08
Mkt. cap
122.98B
Avg. vol.
1.04M
Volume
121.00
P/E ratio
28.23
52-wk high
$560.25
52-wk low
$403.16
EPS
$17.19
Beta
0.28
Shares outstanding
253.46M
No. of employees
6K
Open
$507.55
High
$508.57
Low
$484.08
Mkt. cap
122.98B
Avg. vol.
1.04M
Volume
121.00
P/E ratio
28.23
52-wk high
$560.25
52-wk low
$403.16
EPS
$17.19
Beta
0.28
Shares outstanding
253.46M
No. of employees
6K
News stories
From web sources and news partners
ad-hoc-news.de
·
24 minutes ago
BofA cut target for Vertex Pharma stock from USD 672 to USD 667
MarketWatch
·
14 hours ago
Vertex Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors
Quiver Quantitative
·
16 hours ago
Why Vertex Pharmaceuticals (VRTX) Stock Is Down Today
Investing.com India
·
17 hours ago
Why is Vertex Pharmaceuticals stock sliding 4% today? By Investing.com
Profile
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England. Wikipedia
About Vertex Pharmaceuticals Inc
CEOReshma Kewalramani
Employees6.4K
Founded1989
HeadquartersBoston, Massachusetts, United States
SectorBiotechnology
Websitevrtx.com